Healthcare Services

Infectious Disease Therapeutics Market Growth Forecast With Analysis Of Industry Progress Through 2030

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Infectious Disease Therapeutics Market In 2026 And How Much Will It Reach By 2030?

The infectious disease therapeutics market has demonstrated robust growth in recent years. It is projected to expand from $150.6 billion in 2025 to $160.84 billion in 2026, at a compound annual growth rate (CAGR) of 6.8%. The historical expansion of this market can be attributed to the high global burden of infectious diseases, the extensive use of antibiotics and antivirals, government-led immunization programs, an increase in pharmaceutical manufacturing capacity, and heightened funding for infectious disease research.

The infectious disease therapeutics market is projected for significant expansion over the coming years. Its valuation is forecast to reach $200.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. This growth throughout the forecast period stems from factors such as increasing antimicrobial resistance, more frequent infectious disease outbreaks, broader global vaccination efforts, a rising need for innovative antiviral treatments, and enhanced public health readiness programs. Key trends during this period are expected to involve a heightened emphasis on managing antimicrobial resistance, the accelerated creation of broad-spectrum therapeutic agents, the wider acceptance of combination drug treatments, the growth of fast-acting therapeutics for disease outbreaks, and greater funding for vaccine research and storage.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp

What Important Drivers Are Powering The Infectious Disease Therapeutics Market Growth?

The growing incidence of infectious diseases is anticipated to drive the expansion of the infectious disease therapeutics market in the future. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. The rise in infectious diseases is attributed to several key factors including climate change and environmental disruption, antimicrobial resistance, weakened immune systems, increasing interactions with animals, and ecological disturbances. Infectious disease therapeutics are essential for treating infections, reducing morbidity and mortality, and controlling the spread of communicable diseases within communities and across populations. For instance, in October 2023, the National Health Service (NHS) England, a UK-based government department, reported that in 2022/23, hospitals recorded 147,285 admissions with a primary diagnosis of urinary tract infection (UTI). Patients aged over 65 comprised 56% of these cases, amounting to 82,392 admissions. The 80–84 age group had the highest number of admissions, with 17,280 cases. Therefore, the increasing prevalence of infectious diseases fuels the infectious disease therapeutics market.

What Segment Types Are Included In The Infectious Disease Therapeutics Market Analysis?

The infectious disease therapeutics market covered in this report is segmented –

1) By Type: Drugs, Vaccines

2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases

3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users

Subsegments:

1) By Drugs: Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)

2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines

Which Trends Are Supporting The Evolution Of The Infectious Disease Therapeutics Market?

Major companies operating in the infectious disease therapeutics market are concentrating on incorporating multispecific antibody platforms, such as the multispecific therapeutic antibody reactor (MSTAR), to boost efficacy, expand protection, and enhance responsiveness to emerging viral threats. The multispecific therapeutic antibody reactor (MSTAR) is an advanced multispecific antibody technology that consolidates several independent binding regions into one therapeutic molecule, facilitating capabilities like comprehensive viral neutralization, concurrent targeting of multiple epitopes, and swift adaptation to new variants. For instance, in September 2023, ModeX Therapeutics Inc, a US-based clinical stage biopharmaceutical company, was awarded a contract from the Biomedical Advanced Research and Development Authority. This agreement aims to advance its multispecific antibody candidates, developed for the treatment and prevention of viral infectious diseases, including COVID 19 and influenza, which exhibit broad activity against circulating viral strains, potential compatibility with gene-based delivery using mRNA or DNA vectors, and a multi-binding site architecture. This multispecific antibody approach improves therapeutic outcomes by accelerating development timelines, broadening protective coverage, and simplifying the complexities associated with combination biologic treatments.

Which Firms Are Competing In The Infectious Disease Therapeutics Market?

Major companies operating in the infectious disease therapeutics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, AstraZeneca, Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioCryst Pharmaceuticals Inc.

Access The Complete Infectious Disease Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report

Which Region Is The Dominant Market In The Infectious Disease Therapeutics Market?

North America was the largest region in the infectious disease therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Infectious Disease Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp

Browse Through More Reports Similar to the Global Infectious Disease Therapeutics Market 2026, By The Business Research Company

Infection Control Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Hospital Acquired Infection Control Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Infection Prevention Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795